Global law firm White & Case LLP has advised Kedrion Group S.p.A. on its placement of an aggregate amount of €300 million, 4.625 percent notes due April 2019 to qualified investors outside the United States.
The notes were listed on the Irish Stock Exchange on April 24, 2014.
Established in Italy in 2001, Kedrion is an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating serious diseases, disorders and conditions such as haemophilia and immune system deficiencies.
The White & Case team which advised Kedrion was led by partners Michael S. Immordino (Milan and London), Ferigo Foscari (Milan) and Michael Doran (London) with support from associates I. Anthony Mascarenhas, Jr. (Milan) and Tamara Dyer (London) and lawyer Valentino Belgioioso (Milan).
For more information please speak to your local media contact.